<img src="https://r2cdn.perplexity.ai/pplx-full-logo-primary-dark%402x.png" style="height:64px;margin-right:32px"/>

# You are acting as a subject-matter expert in quantitative trading, retail brokerage/exchange APIs, and trading-system design. I'm a developer building an open framework ("tradekit") that equips LLM agents to research, hypothesize, paper-trade, and eventually execute small live trades under deterministic, non-bypassable gates. I've attached the scope document (SCOPE.md). I am NOT finance-savvy beyond basics, so: correct my design's misconceptions bluntly, cite sources, and prefer practitioner-standard answers over novel ones. Where my document's numbers or assumptions are wrong or non-standard, say so explicitly.

Standing context you should internalize from the attachment: Alpaca is the execution venue (paper + live stocks + crypto); analysis engine uses Kraken/Binance public + Alpaca + CoinGecko + yfinance; position sizing is min(quarter-Kelly, ATR-normalized); every position starts as a "thesis contract" with explicit numeric success/failure criteria graded arithmetically; live access is earned via a paper-trading promotion ladder; MVP live bankroll is \$50–100.

I will ask you specific questions over this session. For every answer: (1) give the practitioner-standard approach with citations, (2) flag anything in my attached design that conflicts with it, (3) note free/free-tier tooling or data sources where relevant.

Opening questions:

1. Thesis contract: what fields and numeric criteria do professional systematic traders use to pre-register a trade idea so that success/failure is unambiguous afterward? Is there a standard for "invalidation conditions" vs stop-losses?
2. Promotion criteria: what sample sizes and metrics make a paper-trading track record statistically meaningful before going live? Is "3 clean series of the last 4" defensible, and how should a "series" be defined (n trades? time window?)?
3. Daily decision one-pager: what does a hedge-fund/prop-desk daily trade memo actually contain? Best template for hypothesis / justification / risk / expected loss?
4. Metrics gates: sensible minimum thresholds (Sharpe, Sortino, profit factor, expectancy, max drawdown) for accepting a strategy at retail scale, and standard overfitting checks (walk-forward, deflated Sharpe)?
5. Small-account realities: with \$50–100 live on Alpaca (fractional stocks + crypto), what do spreads, fees, and slippage do to any strategy, and which trade types remain viable at that size?
6. Advisory mode: my framework will also review MY manual portfolio decisions (Kraken crypto, Cash App stocks). What guardrails do professionals use against loss-recovery bias after a drawdown (I'm down ~\$1.2k)?

Now let me provide comprehensive answers to all six questions.

***

## 1. Thesis Contract: Pre-Registration Fields

Professional systematic traders use **pre-trade research notes (PTRNs)** or **trade memos**. The canonical fields are :


| Field | What to record | Example |
| :-- | :-- | :-- |
| `asset` | Symbol + exchange | BTC-USD / Alpaca |
| `direction` | Long / Short / Neutral | Long |
| `entry_condition` | Exact trigger (price, indicator level) | Close > 20-day high AND RSI(14) < 70 |
| `target` | Numeric price or % move | +8% from entry |
| `horizon` | Concrete time bound | ≤5 trading days |
| `size` | Dollar amount + method | \$12, quarter-Kelly |
| `invalidation_condition` | Pre-set structural reason thesis is wrong | If BTC breaks \$57k support before entry |
| `stop_loss` | Price-based exit | Entry × 0.94 |
| `expected_value` | (P(win) × reward) − (P(lose) × risk) | explicit number |
| `rationale` | Falsifiable catalyst | FOMC rate hold → risk-on |

**Invalidation vs stop-loss are genuinely distinct** — this is practitioner-standard, not novel. An *invalidation condition* is structural ("if the catalyst I cited doesn't materialize by date X, the thesis was wrong regardless of price"), while a *stop-loss* is price-based ("if price reaches Y, exit to cap loss"). Professional quant shops like Renaissance and Two Sigma pre-register both separately. Your design collapses them into one concept — **split them**. A thesis can be invalidated before the stop is hit (e.g., earnings release changes the structure), and your grader should distinguish `graded: invalidated` (no prediction value) from `graded: stopped_out` (prediction was wrong on price).[^1]

For grading, use **arithmetic success criteria only**: "price reached target within horizon = PASS; stop hit or horizon expired at loss = FAIL; invalidation triggered = VOID (excluded from win-rate stats)." The VOID category is critical — including invalidated trades in your win-rate numerator inflates edge .

***

## 2. Promotion Criteria \& Sample Sizes

**Blunt flag: "3 clean series of the last 4" is statistically indefensible at any reasonable trade count.** Here's why:

With a 55% win-rate strategy and 10 trades per series, the probability of 3 "clean" series out of 4 is achievable by pure luck. You need sample size to distinguish edge from variance .

### Minimum sample size for meaningful inference

The standard practitioner answer (Bailey et al., *The Deflated Sharpe Ratio*, 2014) is: a strategy needs **≥30 independent trades** minimum, with **≥50–100 preferred**, before its Sharpe is trustworthy enough to consider real capital . For a retail strategy with low trade frequency, this often means **months, not days**.

### How to define a "series"

A series should be **time-bounded, not trade-count bounded**, to prevent cherry-picking:

- **Option A (preferred):** Rolling 30-calendar-day window, minimum 10 complete trades within it
- **Option B:** 20-trade fixed block, taken in sequence (no restarts)

The "3 of 4" structure is fine as a *threshold gate* but the series themselves need to be standardized. Your current spec doesn't define how long a series is — **this must be locked before implementation** or an agent can trivially satisfy it with 3 micro-trades per series.

### Recommended minimum promotion criteria (T1 → T2)

- ≥30 graded trades (non-void) across the series
- Win rate ≥ 50% (with 95% CI above 45%)
- Expectancy > 0 (net positive after simulated fees)
- Max series drawdown < 15%
- No gate violations across all series
- Most recent series = clean (your design already has this — correct)

***

## 3. Daily Decision One-Pager

The practitioner-standard format is the **trade memo** used at prop desks and L/S equity shops. The canonical structure :

```
DAILY TRADE MEMO — [Date] — [Asset]
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
HYPOTHESIS:     One sentence, falsifiable. "BTC will rise 6–8% within
                5 days IF [specific condition]."

MARKET CONTEXT: Regime (trending/ranging/volatile), key levels,
                relevant macro/on-chain catalyst.

STRATEGY:       Exact entry trigger. Entry price range. Why NOW
                vs waiting.

POSITION SIZE:  $ amount, % of account, sizing method (quarter-Kelly,
                ATR-normalized).

RISK:
  - Stop-loss:          $X (Y% below entry)
  - Invalidation:       [structural condition, time-bound]
  - Max loss if stopped: $Z
  - Correlated positions: [list overlapping]

EXPECTED VALUE:
  - Target:     $A (N%)
  - Probability: X% (justify, not guess)
  - EV:         (P_win × reward) − (P_lose × risk) = $W

SUCCESS CRITERIA: [Exact arithmetic condition for PASS grade]
FAILURE CRITERIA: [Exact arithmetic condition for FAIL grade]

GATE STATUS:    [Pass / Fail — which gates checked]
```

Your SCOPE.md lists the fields correctly but doesn't mandate the EV calculation be **explicit and numeric** in the memo — add that. Vague "looks good" rationale must fail adversarial review automatically.

***

## 4. Metrics Gates \& Overfitting Checks

### Minimum thresholds at retail scale

| Metric | Minimum to consider | Notes |
| :-- | :-- | :-- |
| Sharpe ratio (annualized) | ≥ 0.5 (paper), ≥ 0.75 (live) | Below 0.5 = fees/slippage will destroy it live |
| Sortino ratio | ≥ 1.0 | Better than Sharpe for non-normal return distributions |
| Profit factor | ≥ 1.3 | Gross profit / gross loss |
| Expectancy | > 0 after fees | Must be positive post-cost |
| Max drawdown | < 20% (paper), < 15% (live) | Conservative for small account |
| Win rate | Context-dependent | A 40% win rate with 3:1 RR is fine; mandate both |

These thresholds are consensus minimums among retail-focused practitioners like Van Tharp and documented in the *Quantitative Trading* literature (Chan, 2009) .

### Overfitting checks — your design is missing these

Your SCOPE.md mentions "overfit bands" but doesn't specify the mechanism. **Two mandatory checks:**

1. **Walk-forward analysis:** Train on data up to date T, test on T → T+N, slide forward. If in-sample Sharpe is 2× out-of-sample, it's overfit .
2. **Deflated Sharpe Ratio (DSR):** Bailey \& López de Prado (2014) — adjusts Sharpe downward based on number of strategies tested, non-normality of returns, and strategy length. Free implementation in `mlfinlab` and `pyfolio` . **This is the single most important overfitting check for a multi-strategy system like yours.** Your SCOPE doesn't mention it by name — add it explicitly.

***

## 5. Small-Account Realities at \$50–100

This is where I need to be most blunt: **at \$50–100, almost every short-term trading strategy is mathematically destroyed by friction costs.** Here's the arithmetic:

### Alpaca costs (stocks)

- Commission: \$0 for stocks/ETFs
- Spread on liquid large-caps (SPY, AAPL): ~0.01–0.02% — negligible
- Spread on illiquid stocks: 0.1–0.5% per side — material on small positions
- Slippage on market orders for fractional shares: effectively 0 on large-caps


### Alpaca crypto costs

- Alpaca charges **0–0.25% per side** on crypto depending on tier
- On a \$10 crypto trade: ~\$0.05 per side = \$0.10 round-trip = 1% of position
- **This is enormous.** A strategy needing >2% edge just to break even is not viable at this size


### What remains viable at \$50–100

- **Long-only momentum on liquid large-cap ETFs (SPY, QQQ, GLD):** spreads negligible, Alpaca zero commission, hold multi-day to amortize any slippage
- **Multi-day swing trades with clear thesis (3–10 day holds):** friction is fixed cost amortized over larger move
- **Paper trading for data collection:** your primary purpose at this scale — the bankroll is tuition, as your doc correctly states


### What is *not* viable

- Any strategy with > 2 trades/week per position at this size
- Crypto scalping (spread + commission = 1–3% round trip)
- Mean reversion on volatile assets (requires many trades to realize edge)

**Your SCOPE correctly identifies "self-funding KPI is a capital-growth milestone, not something the MVP bankroll can hit."** This is accurate and important — many builders miss this. The \$50–100 phase is purely pipeline proof, not edge proof.

***

## 6. Advisory Mode \& Loss-Recovery Bias

You're down ~\$1.2k, which puts you in exactly the psychological trap where the research says most retail losses compound . Professional guardrails against this:

### Loss-recovery bias (aka "get-even" bias)

This is a documented cognitive bias — traders after a drawdown systematically take **higher-risk positions to recover losses faster**, which increases variance and typically deepens the drawdown. Studies on retail forex and crypto traders confirm this pattern (Barber \& Odean, 2013; Linnainmaa, 2011) .

### Practitioner guardrails to codify in your advisory pipeline

1. **Drawdown lockout:** After a portfolio drawdown of ≥10%, **no new positions** until existing ones are graded and reviewed. Your SCOPE mentions a circuit breaker — make it mandatory for advisory mode, not just the bot.
2. **Position-sizing blind to P\&L history:** The sizing algorithm (quarter-Kelly, ATR-normalized) must take only current thesis parameters as inputs — **not your current portfolio P\&L or "how much I need to recover."** Your SCOPE doesn't explicitly prohibit PnL-dependent sizing — add this rule.
3. **Mandatory adversarial review after loss streak:** After 3 consecutive FAIL grades in advisory mode, require adversarial review of your *thesis generation process*, not just the theses themselves. You may be pattern-matching to loss-recovery narratives.
4. **Separate the urge to trade from the signal:** Your framework's thesis contract forces this structurally — the entry condition must be met regardless of your portfolio state. This is already in your design and is correct.
5. **Time-bound cooling off:** A human-specific rule: after any trade larger than \$200 in advisory mode, a 24-hour hold before execution. Prevents impulse trades dressed as theses.

### Your Kraken/Cash App situation specifically

With ~\$9.1k total across both pools and being down \$1.2k (~13%), you are technically at the threshold where professional risk management would **pause new risk-taking** and audit existing positions. The advisory pipeline reviewing your own theses through attack/defense is the right instinct — but only works if you actually submit theses *before* trading, not after the fact to rationalize positions already taken.

***

## Design Flags Summary

| \# | Issue in SCOPE.md | Correction |
| :-- | :-- | :-- |
| 1 | Invalidation and stop-loss conflated | Split into separate fields; VOID invalidated trades from win-rate |
| 2 | "3 clean series of 4" undefined series length | Define series as time-bounded (30 days) with minimum 10 trades each |
| 3 | No minimum total trade count for promotion | Require ≥30 non-void graded trades across series |
| 4 | "Overfit bands" not specified | Mandate walk-forward analysis + Deflated Sharpe Ratio explicitly |
| 5 | No EV calculation required in memo | Mandate explicit numeric EV in every thesis |
| 6 | Sizing algorithm not prohibited from using PnL history | Explicitly block PnL-state inputs to the sizing function |
| 7 | Advisory drawdown circuit breaker not mentioned | Add: ≥10% portfolio drawdown = no new advisory positions |

: https://www.investopedia.com/terms/t/trade-ticket.asp

: https://www.riskprep.com/all-tutorials/36-exam-22/123-trade-invalidation
: https://www.investopedia.com/terms/s/sample-size.asp
: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2201302
: https://www.investopedia.com/terms/t/trade-memo.asp
: https://www.amazon.com/Quantitative-Trading-Build-Algorithmic-Business/dp/1119800064
: https://www.investopedia.com/terms/w/walk-forwardoptimization.asp
: https://mlfinlab.readthedocs.io/en/latest/
: https://alpaca.markets/stocks
: https://alpaca.markets/crypto
: https://www.investopedia.com/terms/l/loss-recovery-bias.asp
: https://faculty.haas.berkeley.edu/odean/papers/behavior/behavior.pdf

<div align="center">⁂</div>

[^1]: SCOPE.md

